NIH-funded research R21 grant

Understanding how a protein affects antibody development

Official title: The Role of UNG2 Degradation in Antibody Maturation

Funded at Wayne State University · NIH-11097200 · Data updated 2026-11-12

This study is looking at how a protein called mFAM72A helps improve the way our immune system makes antibodies, which are important for fighting off infections, and it could lead to better treatments for people with immune-related conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startJune 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$228,200
NIH project number5R21AI180183-02
Project IDNIH-11097200 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with conditions that affect antibody production or those who are immunocompromised.

Less likely to help

Patients with stable immune function and no history of antibody-related disorders may not receive direct benefits from this research.

What this research studies

This research investigates the role of a specific protein, mFAM72A, in the maturation of antibodies, which are crucial for the immune response. It focuses on how mFAM72A interacts with another protein, mUNG2, to regulate processes that enhance the effectiveness of antibodies. By examining the degradation of mUNG2, the research aims to uncover mechanisms that could improve antibody responses in patients. The study uses advanced molecular biology techniques to analyze these interactions in B lymphocytes, which are vital for producing antibodies.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for enhancing antibody responses, potentially benefiting patients with weakened immune systems or those undergoing treatments like chemotherapy.

How similar studies have gone: Other research has shown promising results in understanding antibody maturation processes, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Bhagwat, Ashok S — Wayne State University
  • Study coordinator: Bhagwat, Ashok S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.